State Of Wisconsin Investment Board Phathom Pharmaceuticals, Inc. Transaction History
State Of Wisconsin Investment Board
- $36.9 Billion
- Q4 2024
A detailed history of State Of Wisconsin Investment Board transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 132,269 shares of PHAT stock, worth $763,192. This represents 0.0% of its overall portfolio holdings.
Number of Shares
132,269
Previous 81,770
61.76%
Holding current value
$763,192
Previous $1.48 Million
27.33%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PHAT
# of Institutions
156Shares Held
70.6MCall Options Held
55.5KPut Options Held
285K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$58.3 Million9.84% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$43.1 Million13.31% of portfolio
-
Jennison Associates LLC7.06MShares$40.8 Million0.04% of portfolio
-
Invesco Ltd. Atlanta, GA3.67MShares$21.2 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$20.2 Million28.4% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $226M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...